SPPI stock forecast
Our latest prediction for Spectrum Pharmaceuticals, Inc.'s stock price was made on the Jan. 17, 2020 when the stock price was at 3.24$.
In the short term (2weeks), SPPI's stock price should outperform the market by 4.96%. During that period the price should oscillate between -10.75% and +28.21%.
In the medium term (3months), SPPI's stock price should outperform the market by 8.85%. During that period the price should oscillate between -36.15% and +61.08%.Get email alerts
About Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.
At the moment the company generates 109M USD in revenues.
On its last earning announcement, the company reported a loss of -1.13$ per share.
The book value per share is 3.25$
Three months stock forecastJan. 17, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|